Effectiveness of 12-month GnRH antagonist treatment for endometriosis-associated pain: driven by reduction in uterine bleeding?
Human Reproduction Open · 12.03.2026 · 2026 (2)
DOI: 10.1093/hropen/hoag031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction Open, online erschienen am 08.04.2026. Verfasst von Thomas M D'Hooghe. Beteiligte Einrichtung: Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of …. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, Belgium.
- Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
- Global Medical Unit Fertility, Research and Development, Merck Healthcare KGaA, Darmstadt, Germany.
ORCID-Profile: Thomas M D'Hooghe
Zitieren
APA
D'Hooghe, T. M. (2026). Effectiveness of 12-month GnRH antagonist treatment for endometriosis-associated pain: driven by reduction in uterine bleeding?. Human Reproduction Open, 2026(2). https://doi.org/10.1093/hropen/hoag031
Vancouver
D'Hooghe TM. Effectiveness of 12-month GnRH antagonist treatment for endometriosis-associated pain: driven by reduction in uterine bleeding?. Human Reproduction Open. 2026;2026(2). doi:10.1093/hropen/hoag031
BibTeX
@article{DHooghe2026,
author = {D'Hooghe, Thomas M},
title = {Effectiveness of 12-month GnRH antagonist treatment for endometriosis-associated pain: driven by reduction in uterine bleeding?},
journal = {Human Reproduction Open},
year = {2026},
volume = {2026},
number = {2},
doi = {10.1093/hropen/hoag031}
}
EUVIMED